Retatrutide, by Soma Chems , is attracting considerable attention as a innovative therapy for weight regulation. This dual-action compound merges the activity of a GLP-1 receptor agonist and a GIP receptor stimulant, intended to effectively promote weight loss but also improve associated metaboli